Physician profile
Ian Engler
NPI 1225485808
$47,286.95
in general payments reported to CMS, 2019-2025
12 companies · $1,126 in 2025
The $1,126 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $446 · 2021: $23K · 2022: $20K · 2023: $2,063 · 2024: $140 · 2025: $1,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,817 · Food and Beverage: $1,512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,816.73 |
| Food and Beverage | $1,511.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $20,718.13 | 2021-2022 | |
| Arthrex, INC. | $14,187.48 | 2021-2023 | |
| Smith+Nephew, INC. | $7,110.76 | 2021-2022 | |
| Stryker Corporation | $3,581.36 | 2019-2025 | Blueprint Patient Specific Instrumentation, Iconix, Formula |
| Medical Device Business Services, INC. | $730.51 | 2019-2021 | |
| Kairos Surgical INC | $275.97 | 2022-2025 | |
| Encore Medical, Lp | $267.25 | 2020-2022 | |
| Exactech, INC. | $143.13 | 2021 | |
| Pacira Therapeutics, INC. | $125.00 | 2019 | |
| Depuy Synthes Sales INC. | $78.19 | 2024-2025 | Na |
| Integra Lifesciences Corporation | $52.71 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $16.46 | 2025 | Comprehensive Shoulder System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Engler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.